NeoDiagnostix provides health measurement devices within the health technology sector. The company offers devices that monitor and measure various health parameters for individuals to track health metrics. It is based in Rockville, Maryland.

Predict to Prevent  Prognomixs vision is the development of personalized medicine for the early detection of susceptibilities to diseases their complications and individual therapeutic responsiveness using genomic signatures Their initial focus is the development  of  presymptomatic diagnostic tools of diabetic complications based on genomic signatures aimed at individualized targeted prevention

CivaTech Oncology focuses on localized radiation therapy within the medical devices sector. The company specializes in developing polymer-based low dose rate brachytherapy devices designed to treat various stages of cancer by providing targeted radiation therapy. Its products, including CivaSheet, CivaString, and CivaDerm, offer customizable solutions for radiation oncologists to deliver individualized treatment, aiming to reduce procedure time, ensure homogeneous dose distribution, and minimize patient trauma. It was founded in 2006 and is based in Durham, North Carolina.

XDx is a molecular diagnostics company focused on the discovery, development and commercialization of non-invasive gene expression testing in the areas of transplant medicine and autoimmunity. Per the company, they have developed a proprietary method of utilizing gene expression in blood that aims to provide a new tool for physicians to manage the care of heart transplant patients. The molecular expression technology developed and implemented by XDx in heart transplant patient management is currently being explored to assist with other diseases that involve the immune system.

theraGenetics is a personalized medicine diagnostics company developing pharmacogenetic tests to guide and improve the treatment of central nervous system (CNS) disorders; matching the medication to the patient.

Glycominds is a diagnostics company focused on biomarkers for autoimmune and chronic inflammatory diseases within the gastroenterology sector. The company provides diagnostic solutions for conditions like Inflammatory Bowel Disease (IBD), including Crohn's Disease and Ulcerative Colitis. Glycominds serves the healthcare industry. It is based in Redwood City, California.